NCT07433010 · RECRUITING

German Dementia Registry

This is a registry, not a treatment trial. The German Dementia Registry collects clinical information and biomarker results, such as spinal fluid or brain scan markers, from people with memory complaints, mild cognitive impairment, or early dementia. Nothing is being tested or given. The data builds a shared platform for future research. No phase applies.

Eligibility criteria

Inclusion Criteria:
Inclusion Criteria for Patient:
* Ability of the participant and/or his/her legally authorized representative (e.g., spouse or legal guardian), as appropriate and applicable, to understand the purpose and risks of the register and provide signed and dated informed consent and authorization to use protected health information (PHI) in accordance with national and local privacy regulations.
* Participating patients must have a diagnosis of SCD, MCI or early dementia of different etiology (i.e. Alzheimer's Disease, Frontotemporal Dementia, Parkinson's Disease, Lewy-Body Dementia, Progressive Supranuclear Palsy, Corticobasal Degeneration, Normal Pressure Hydrocephalus, Major Depression; Vascular Dementia; TDP-43 associated limbic encephalopathy (LATE), Mixed Dementia AD + VaD, Prion-Associated Dementia) together with biomarkers such as cerebrospinal fluids (CSF) amyloid beta 1-42, amyloid beta 1-40, amyloid beta 1-42/amyloid beta 1-40 ratio, total tau and phosphorylated tau, amyloid or tau imaging.
* At least 18 years of age.
Inclusion Criteria for family member:
* At least 18 years of age.
* Patient was included in the registry
* Family member is strongly involved to the patient's life according to the patient's statement
* Ability of the participant, as appropriate and applicable, to understand the purpose and risks of the register
Exclusion Criteria:
Exclusion Criteria for Patient:
* Unwilling to provide informed consent.
* No available biomarkers such as cerebrospinal fluids (CSF) amyloid beta 1-42, amyloid beta 1-40, amyloid beta 1-42/amyloid beta 1-40 ratio, total tau and phosphorylated tau, amyloid or tau imaging.
Exclusion Criteria for family member:
* Unable or unwilling to provide informed consent.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-02-25

View full record on ClinicalTrials.gov

All APOE4 clinical trials